Covid-19: Govt eyes 51 crore vaccine doses by July

By: |
May 28, 2021 6:00 AM

By July, there would be a total of 51.6 crore doses, VK Paul, member, health, Niti Aayog and chair of the National Expert Group on Vaccine Administration for Covid-19, said. He said the government was doing everything to increase development, production and supply of ‘made in India’ vaccines.

covid 19 vaccines, covid 19 pandemicIn February 2021, Serum Institute’s Poonawalla shared that patents are not an impediment to speedy vaccine rollout and that “it just takes time to scale up”. (Representational image)

The country is back to administering 20 lakh doses of Covid-19 vaccines per day and this will increase further.

By July, there would be a total of 51.6 crore doses, VK Paul, member, health, Niti Aayog and chair of the National Expert Group on Vaccine Administration for Covid-19, said. He said the government was doing everything to increase development, production and supply of ‘made in India’ vaccines.

All the vaccine manufacturers were increasing their monthly capacities to inoculate maximum number of people. Bharat Biotech started with 99 lakh doses of COVAXIN a month, which is expected to reach 10 crore per month by September or October. Serum Institute is ramping up Covishield production from 6.5 crore doses per month dose level to 11 crore doses per per month.

Additionally, three PSUs — Haffkine Biopharmaceutical Corporation, Mumbai, Bharat Immunologicals and Biologicals Corporation, Bulandshahr and Indian Immunologicals, Hyderabad — will together aim to produce up to four crore doses of COVAXIN by December.

Russia has already sent two tranches of vaccines and also accomplished tech-transfer to Indian companies that would start manufacturing very soon. The Sputnik vaccine will be manufactured by six companies coordinated by Dr Reddy’s.

There was also steady progress being made in the development of Zydus Cadila, BioE and Gennova vaccine.

Development of Bharat Biotech’s single dose intranasal vaccine was proceeding well with government funding, and it could be a game-changer for the world, Paul said.

He said that vaccine availability was going to increase in the near future and much more supply would be possible. The estimated production of over 200 crore doses by the vaccine industry by the end of 2021 would be the result of these efforts, he said.

Paul said the country was on the downswing of the second wave of the pandemic and he hoped it would be sustained. It would be sustained even when the restrictions were gently, systematically and cautiously opened up , he said.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1New research shows how shelf-life of RT-PCR test kits can be increased to 30 days at room temperature
2International Yoga Day 2021: Yoga Asanas for immunity
3‘Delta plus’ variant, complacency might bring ferocious 3rd wave in few months: Maharashtra Covid task force